Additionally, the pathway intersects with Wnt/β‐catenin signaling; for instance, in colorectal cancer, AMPK phosphorylates ubiquitin‐specific peptidase 10 (USP10) to inhibit Wnt/β‐catenin signaling and impede tumor progression [81]. Here, PRKAA2 is linked to neoplasm.